[PERSON]
GLP-1 receptor agonists
Featured in 2 tracked stories · first seen
Situations
GLP-1 obesity drug rollout and market expansion
105 clusters · 510 sources · last updated
Latest: Novo Nordisk reports pediatric obesity trial success amid market pressure
Novo Nordisk continues to expand its GLP-1 market presence, maintaining approximately a 43% global market share for obesity and diabetes treatments despite competition from Eli Lilly. The oral Wegovy pill remains a prima